AstraZeneca India, 4baseCare join hands to enhance access to genomic testing for cancer patients in India

Mumbai (Maharashtra) [India], November 9 (ANI): India’s leading precision oncology start-up 4baseCare on Wednesday announced a collaboration with AstraZeneca India for advancing cancer care in India. Under this pact, these firms will support advanced-stage cancer patients with targeted therapy options using affordable genomic solutions.

AstraZeneca and 4baseCare will work with the oncologist community to support a large number of patients by providing these services locally and also at a low cost, ultimately increasing the chances of identifying optimal treatment options thereby improving clinical outcomes, the startup said in a statement.

Click here to read the entire article.